Insider · CIK 0001806919
Eric Rothe
Files at GLSI (Greenwich LifeSciences, Inc.). First filing -, latest -.
Eric Rothe files SEC Form 4 as director at GLSI (Greenwich LifeSciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eric Rothe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | GLSI Greenwich LifeSciences, Inc. | AGrant or award Stock Optionsderivative | +41,349 | $0.00 | $0 | 82,698 | Dec 27, 2024 |
Questions about Eric Rothe
Answered from the filings on this page, as of the latest one.
Is Eric Rothe buying or selling?
Eric Rothe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eric Rothe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric Rothe has 0.
Where does Eric Rothe file Form 4?
Eric Rothe has filed Form 4 at GLSI (Greenwich LifeSciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.